These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 22735219)

  • 1. Association between non-alcoholic fatty liver disease and liver function/injury markers with metabolic syndrome components in class III obese individuals.
    Chaves GV; Souza DS; Pereira SE; Saboya CJ; Peres WA
    Rev Assoc Med Bras (1992); 2012; 58(3):288-93. PubMed ID: 22735219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonalcoholic Fatty Liver Disease Relationship with Metabolic Syndrome in Class III Obesity Individuals.
    Cordeiro A; Pereira SE; Saboya CJ; Ramalho A
    Biomed Res Int; 2015; 2015():839253. PubMed ID: 26120587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Body mass index and waist circumference in non-alcoholic fatty liver disease.
    Rocha R; Cotrim HP; Carvalho FM; Siqueira AC; Braga H; Freitas LA
    J Hum Nutr Diet; 2005 Oct; 18(5):365-70. PubMed ID: 16150132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Predictors of liver fibrosis in patients with non-alcoholic fatty liver disease. The role of metabolic syndrome, insulin-resistance and inflammation].
    Andreozzi P; Viscogliosi G; Colella F; Subic M; Cipriani E; Marigliano B; Verrusio W; Servello A; Ettorre E; Marigliano V
    Recenti Prog Med; 2012 Dec; 103(12):570-4. PubMed ID: 23258240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ultrasonographically detected non-alcoholic fatty liver disease is an independent predictor for identifying patients with insulin resistance in non-obese, non-diabetic middle-aged Asian adults.
    Sinn DH; Gwak GY; Park HN; Kim JE; Min YW; Kim KM; Kim YJ; Choi MS; Lee JH; Koh KC; Paik SW; Yoo BC
    Am J Gastroenterol; 2012 Apr; 107(4):561-7. PubMed ID: 22108448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of non-alcoholic fatty liver disease in women with polycystic ovary syndrome and its correlation with metabolic syndrome.
    Romanowski MD; Parolin MB; Freitas AC; Piazza MJ; Basso J; Urbanetz AA
    Arq Gastroenterol; 2015; 52(2):117-23. PubMed ID: 26039829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The value of different insulin resistance indices in assessment of non-alcoholic fatty liver disease in overweight/obese children.
    El-Karaksy HM; El-Raziky MS; Fouad HM; Anwar GM; El-Mougy FM; El-Koofy NM; El-Hennawy AM
    Diabetes Metab Syndr; 2015; 9(2):114-9. PubMed ID: 25470627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-alcoholic fatty liver disease in young adult severely obese non-diabetic patients in South Italy.
    Colicchio P; Tarantino G; del Genio F; Sorrentino P; Saldalamacchia G; Finelli C; Conca P; Contaldo F; Pasanisi F
    Ann Nutr Metab; 2005; 49(5):289-95. PubMed ID: 16088092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Nonalcoholic fatty liver disease and its association with metabolic syndrome in the preoperative period in patients undergoing bariatric surgery].
    Schild BZ; Santos LN; Alves MK
    Rev Assoc Med Bras (1992); 2013; 59(2):155-60. PubMed ID: 23582557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-alcoholic fatty liver disease and its associated risk factors in Brazilian postmenopausal women.
    Bruno Ade S; Rodrigues MH; Alvares MC; Nahas-Neto J; Nahas EA
    Climacteric; 2014 Aug; 17(4):465-71. PubMed ID: 24517420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Additive Effect of Non-Alcoholic Fatty Liver Disease on Metabolic Syndrome-Related Endothelial Dysfunction in Hypertensive Patients.
    Perticone M; Cimellaro A; Maio R; Caroleo B; Sciacqua A; Sesti G; Perticone F
    Int J Mol Sci; 2016 Mar; 17(4):456. PubMed ID: 27023537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of uric acid levels with components of metabolic syndrome and non-alcoholic fatty liver disease in overweight or obese children and adolescents.
    Cardoso AS; Gonzaga NC; Medeiros CC; Carvalho DF
    J Pediatr (Rio J); 2013; 89(4):412-8. PubMed ID: 23791233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of clinical and inflammatory markers of nonalcoholic fatty liver disease in postmenopausal women with metabolic syndrome.
    Rodrigues MH; Bruno AS; Nahas-Neto J; Sandrim VC; Muniz LG; Nahas EA
    Metab Syndr Relat Disord; 2014 Aug; 12(6):330-8. PubMed ID: 25051240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of nonalcoholic fatty liver disease with metabolic syndrome in Indian population.
    Sanal MG; Sarin SK
    Diabetes Metab Syndr; 2011; 5(2):76-80. PubMed ID: 22813407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic syndrome and biochemical changes among non-alcoholic fatty liver disease patients attending a tertiary care hospital of Nepal.
    Pardhe BD; Shakya S; Bhetwal A; Mathias J; Khanal PR; Pandit R; Shakya J; Joshi HO; Marahatta SB
    BMC Gastroenterol; 2018 Jul; 18(1):109. PubMed ID: 29980170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence, risk factors, and predictors of nonalcoholic fatty liver disease among schoolchildren: a hospital-based study in Alexandria, Egypt.
    Alkassabany YM; Farghaly AG; El-Ghitany EM
    Arab J Gastroenterol; 2014 Jun; 15(2):76-81. PubMed ID: 25097051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonalcoholic fatty liver disease in severely obese subjects.
    Gholam PM; Flancbaum L; Machan JT; Charney DA; Kotler DP
    Am J Gastroenterol; 2007 Feb; 102(2):399-408. PubMed ID: 17311652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-alcoholic fatty liver disease fibrosis score and preclinical vascular damage in morbidly obese patients.
    Gentili A; Daviddi G; De Vuono S; Ricci MA; Di Filippo F; Alaeddin A; Mannarino MR; Boni M; Vaudo G; Lupattelli G
    Dig Liver Dis; 2016 Aug; 48(8):904-8. PubMed ID: 27160697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of metabolic syndrome parameters with TT3 and FT3/FT4 ratio in obese Turkish population.
    Tarcin O; Abanonu GB; Yazici D; Tarcin O
    Metab Syndr Relat Disord; 2012 Apr; 10(2):137-42. PubMed ID: 22229843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of non-alcoholic fatty liver disease on chronic hepatitis B.
    Bondini S; Kallman J; Wheeler A; Prakash S; Gramlich T; Jondle DM; Younossi ZM
    Liver Int; 2007 Jun; 27(5):607-11. PubMed ID: 17498244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.